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I have read with great interest the review by Peter rise during the first 18-24 h of treatment with quinine, 
Winstanley, ‘Coping with malaria in the face of resist- and that this is not reliable evidence for drug failure. 
ante’, in the December issue of the journal. I am wondering why a parasite count should be 
In his review, Winstanley recommends that, if done 6-hourly if it is not going to influence the treat- 
possible, blood slides should be examined 6-hourly, and ment. Our present recommendation is to examine a 
a quantitative parasite count done. He also mentions blood slide on the next day. Is there any reason why this 
that parasite counts often remained unchanged and may should be changed 
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I am grateful to Dr Shah for his comments on the 
frequency with which blood slides should be done 
during the treatment of severe falciparum malaria with 
intravenous quinine. 1 think that this is a matter of 
‘counsel of perfection’ versus a practical approach to the 
patient. Dr Shah is, I think, entirely logical when he 
questions whether 6-hourly parasite counts are needed 
on the first day, given that parasitemia is unlikely to 
change in the first 18-24 h of quinine administration. Dr 
Shah indicates that his institution measures the parasite 
count upon presentation and 24 h after the start of 
intravenous quinine administration. While this would 
provide insufficient data to estimate parasite clearance 
times, such measurements are usually a clinical trial tool, 
and are not needed in standard clinical practice. 
However, the artemisinin drugs are being used 
increasingly for severe malaria, and earlier and more 
frequent parasite counts may be valuable in the setting 
of treatment with intramuscular artemether. The 
intramuscular route (unlike intravenous administration) 
requires drug absorption for therapeutic effects to be 
obtained. In the case of artemether, there is concern that 
very sick children with cerebral malaria (especially 
those with acidosis) may absorb intramuscular arte- 
mether unreliab1y.l Parasite counts should fall more 
rapidly with the artemisinin drugs than with quinine, and 
so the failure of counts to fall within the first 24 h of 
intramuscular artemether should probably lead to 
clinical concern. 
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